Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, safety, pharmacokinetics (PK) and
pharmacodynamics (PD) of rivaroxaban in the treatment of pulmonary embolism (PE) and the
prevention of the occurrence and the recurrence of deep vein thrombosis (DVT) or PE in
Japanese patients with acute symptomatic PE with or without symptomatic DVT.